{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:58:09Z","timestamp":1793383089726,"version":"4.5.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,6,12]],"date-time":"2009-06-12T00:00:00Z","timestamp":1244764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1038\/hr.2009.86","type":"journal-article","created":{"date-parts":[[2009,6,12]],"date-time":"2009-06-12T07:33:20Z","timestamp":1244792000000},"page":"649-657","source":"Crossref","is-referenced-by-count":53,"title":["Mineralocorticoid receptor activation in obesity hypertension"],"prefix":"10.1038","volume":"32","author":[{"given":"Miki","family":"Nagase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,12]]},"reference":[{"key":"BFhr200986_CR1","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1126\/science.307.5716.1716","volume":"307","author":"CC Mann","year":"2005","unstructured":"Mann CC . Public health. Provocative study says obesity may reduce US life expectancy. Science 2005; 307: 1716\u20131717.","journal-title":"Science"},{"key":"BFhr200986_CR2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0092-8674(03)01081-X","volume":"116","author":"JS Flier","year":"2004","unstructured":"Flier JS . Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004; 116: 337\u2013350.","journal-title":"Cell"},{"key":"BFhr200986_CR3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","volume":"109","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C . Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433\u2013438.","journal-title":"Circulation"},{"key":"BFhr200986_CR4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","volume":"444","author":"JP Despres","year":"2006","unstructured":"Despres JP, Lemieux I . Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881\u2013887.","journal-title":"Nature"},{"key":"BFhr200986_CR5","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJMra043590","volume":"353","author":"AI Shulman","year":"2005","unstructured":"Shulman AI, Mangelsdorf DJ . Retinoid x receptor heterodimers in the metabolic syndrome. N Engl J Med 2005; 353: 604\u2013615.","journal-title":"N Engl J Med"},{"key":"BFhr200986_CR6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.tem.2006.07.004","volume":"17","author":"JF Tobin","year":"2006","unstructured":"Tobin JF, Freedman LP . Nuclear receptors as drug targets in metabolic diseases: new approaches to therapy. Trends Endocrinol Metab 2006; 17: 284\u2013290.","journal-title":"Trends Endocrinol Metab"},{"key":"BFhr200986_CR7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nm1025","volume":"10","author":"RM Evans","year":"2004","unstructured":"Evans RM, Barish GD, Wang YX . PPARs and the complex journey to obesity. Nat Med 2004; 10: 355\u2013361.","journal-title":"Nat Med"},{"key":"BFhr200986_CR8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","volume":"83","author":"DJ Mangelsdorf","year":"1995","unstructured":"Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM . The nuclear receptor superfamily: the second decade. Cell 1995; 83: 835\u2013839.","journal-title":"Cell"},{"key":"BFhr200986_CR9","doi-asserted-by":"crossref","first-page":"12729","DOI":"10.1073\/pnas.97.23.12729","volume":"97","author":"PA Heine","year":"2000","unstructured":"Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS . Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 2000; 97: 12729\u201312734.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFhr200986_CR10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jsbmb.2008.03.017","volume":"109","author":"T Yanase","year":"2008","unstructured":"Yanase T, Fan W, Kyoya K, Min L, Takayanagi R, Kato S, Nawata H . Androgens and metabolic syndrome: lessons from androgen receptor knock out (ARKO) mice. J Steroid Biochem Mol Biol 2008; 109: 254\u2013257.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFhr200986_CR11","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1126\/science.1066285","volume":"294","author":"H Masuzaki","year":"2001","unstructured":"Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS . A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294: 2166\u20132170.","journal-title":"Science"},{"key":"BFhr200986_CR12","doi-asserted-by":"crossref","first-page":"15712","DOI":"10.1073\/pnas.2536828100","volume":"100","author":"W He","year":"2003","unstructured":"He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E, Olefsky JM, Evans RM . Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci USA 2003; 100: 15712\u201315717.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFhr200986_CR13","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1073\/pnas.0511253103","volume":"103","author":"CH Lee","year":"2006","unstructured":"Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM, Gonzalez FJ, Ham J, Kang H, Peters JM, Evans RM . PPARdelta regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci USA 2006; 103: 3444\u20133449.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFhr200986_CR14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.0197-3118.2006.05422.x","volume":"1","author":"AM Sharma","year":"2006","unstructured":"Sharma AM, Engeli S . The role of renin-angiotensin system blockade in the management of hypertension associated with the cardiometabolic syndrome. J Cardiometab Syndr 2006; 1: 29\u201335.","journal-title":"J Cardiometab Syndr"},{"key":"BFhr200986_CR15","doi-asserted-by":"crossref","first-page":"R943","DOI":"10.1152\/ajpregu.00265.2004","volume":"287","author":"CM Boustany","year":"2004","unstructured":"Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA . Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 2004; 287: R943\u2013R949.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFhr200986_CR16","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1681\/ASN.2006080944","volume":"17","author":"M Nagase","year":"2006","unstructured":"Nagase M, Yoshida S, Shibata S, Nagase T, Gotoda T, Ando K, Fujita T . Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J Am Soc Nephrol 2006; 17: 3438\u20133446.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr200986_CR17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/HYPERTENSIONAHA.107.091058","volume":"50","author":"M Nagase","year":"2007","unstructured":"Nagase M, Matsui H, Shibata S, Gotoda T, Fujita T . Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress. Hypertension 2007; 50: 877\u2013883.","journal-title":"Hypertension"},{"key":"BFhr200986_CR18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/HYPERTENSIONAHA.108.111815","volume":"52","author":"H Matsui","year":"2008","unstructured":"Matsui H, Ando K, Kawarazaki H, Nagae A, Fujita M, Shimosawa T, Nagase M, Fujita T . Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder. Hypertension 2008; 52: 287\u2013294.","journal-title":"Hypertension"},{"key":"BFhr200986_CR19","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/01.HYP.0000222003.28517.99","volume":"47","author":"M Nagase","year":"2006","unstructured":"Nagase M, Shibata S, Yoshida S, Nagase T, Gotoda T, Fujita T . Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension 2006; 47: 1084\u20131093.","journal-title":"Hypertension"},{"key":"BFhr200986_CR20","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.HYP.0000203772.78696.67","volume":"47","author":"K Nagata","year":"2006","unstructured":"Nagata K, Obata K, Xu J, Ichihara S, Noda A, Kimata H, Kato T, Izawa H, Murohara T, Yokota M . Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats. Hypertension 2006; 47: 656\u2013664.","journal-title":"Hypertension"},{"key":"BFhr200986_CR21","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm.1879","volume":"14","author":"S Shibata","year":"2008","unstructured":"Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, Miyoshi J, Takai Y, Fujita T . Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med 2008; 14: 1370\u20131376.","journal-title":"Nat Med"},{"key":"BFhr200986_CR22","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1172\/JCI1915","volume":"101","author":"MC Zennaro","year":"1998","unstructured":"Zennaro MC, Le Menuet D, Viengchareun S, Walker F, Ricquier D, Lombes M . Hibernoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action. J Clin Invest 1998; 101: 1254\u20131260.","journal-title":"J Clin Invest"},{"key":"BFhr200986_CR23","doi-asserted-by":"crossref","first-page":"E640","DOI":"10.1152\/ajpendo.2001.280.4.E640","volume":"280","author":"S Viengchareun","year":"2001","unstructured":"Viengchareun S, Penfornis P, Zennaro MC, Lombes M . Mineralocorticoid and glucocorticoid receptors inhibit UCP expression and function in brown adipocytes. Am J Physiol Endocrinol Metab 2001; 280: E640\u2013E649.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFhr200986_CR24","doi-asserted-by":"crossref","first-page":"38911","DOI":"10.1074\/jbc.M103984200","volume":"276","author":"D Le Menuet","year":"2001","unstructured":"Le Menuet D, Isnard R, Bichara M, Viengchareun S, Muffat-Joly M, Walker F, Zennaro MC, Lombes M . Alteration of cardiac and renal functions in transgenic mice overexpressing human mineralocorticoid receptor. J Biol Chem 2001; 276: 38911\u201338920.","journal-title":"J Biol Chem"},{"key":"BFhr200986_CR25","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ng.361","volume":"41","author":"C Newton-Cheh","year":"2009","unstructured":"Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, Najjar SS, Zhao JH, Heath SC, Eyheramendy S, Papadakis K, Voight BF, Scott LJ, Zhang F, Farrall M, Tanaka T, Wallace C, Chambers JC, Khaw KT, Nilsson P, van der Harst P, Polidoro S, Grobbee DE, Onland-Moret NC, Bots ML, Wain LV, Elliott KS, Teumer A, Luan J, Lucas G, Kuusisto J, Burton PR, Hadley D, McArdle WL, Brown M, Dominiczak A, Newhouse SJ, Samani NJ, Webster J, Zeggini E, Beckmann JS, Bergmann S, Lim N, Song K, Vollenweider P, Waeber G, Waterworth DM, Yuan X, Groop L, Orho-Melander M, Allione A, Di Gregorio A, Guarrera S, Panico S, Ricceri F, Romanazzi V, Sacerdote C, Vineis P, Barroso I, Sandhu MS, Luben RN, Crawford GJ, Jousilahti P, Perola M, Boehnke M, Bonnycastle LL, Collins FS, Jackson AU, Mohlke KL, Stringham HM, Valle TT, Willer CJ, Bergman RN, Morken MA, Doring A, Gieger C, Illig T, Meitinger T, Org E, Pfeufer A, Wichmann HE, Kathiresan S, Marrugat J, O\u2019Donnell CJ, Schwartz SM, Siscovick DS, Subirana I, Freimer NB, Hartikainen AL, McCarthy MI, O\u2019Reilly PF, Peltonen L, Pouta A, de Jong PE, Snieder H, van Gilst WH, Clarke R, Goel A, Hamsten A, Peden JF, Seedorf U, Syvanen AC, Tognoni G, Lakatta EG, Sanna S, Scheet P, Schlessinger D, Scuteri A, Dorr M, Ernst F, Felix SB, Homuth G, Lorbeer R, Reffelmann T, Rettig R, Volker U, Galan P, Gut IG, Hercberg S, Lathrop GM, Zelenika D, Deloukas P, Soranzo N, Williams FM, Zhai G, Salomaa V, Laakso M, Elosua R, Forouhi NG, Volzke H, Uiterwaal CS, van der Schouw YT, Numans ME, Matullo G, Navis G, Berglund G, Bingham SA, Kooner JS, Connell JM, Bandinelli S, Ferrucci L, Watkins H, Spector TD, Tuomilehto J, Altshuler D, Strachan DP, Laan M, Meneton P, Wareham NJ, Uda M, Jarvelin MR, Mooser V, Melander O, Loos RJ, Elliott P, Abecasis GR, Caulfield M, Munroe PB . Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009; 41: 666\u2013676.","journal-title":"Nat Genet"},{"key":"BFhr200986_CR26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ng.384","volume":"41","author":"D Levy","year":"2009","unstructured":"Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, Glazer NL, Morrison AC, Johnson AD, Aspelund T, Aulchenko Y, Lumley T, Kottgen A, Vasan RS, Rivadeneira F, Eiriksdottir G, Guo X, Arking DE, Mitchell GF, Mattace-Raso FU, Smith AV, Taylor K, Scharpf RB, Hwang SJ, Sijbrands EJ, Bis J, Harris TB, Ganesh SK, O\u2019Donnell CJ, Hofman A, Rotter JI, Coresh J, Benjamin EJ, Uitterlinden AG, Heiss G, Fox CS, Witteman JC, Boerwinkle E, Wang TJ, Gudnason V, Larson MG, Chakravarti A, Psaty BM, van Duijn CM . Genome-wide association study of blood pressure and hypertension. Nat Genet 2009; 41: 677\u2013687.","journal-title":"Nat Genet"},{"key":"BFhr200986_CR27","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1001\/jama.1978.03290150053024","volume":"240","author":"R Stamler","year":"1978","unstructured":"Stamler R, Stamler J, Riedlinger WF, Algera G, Roberts RH . Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA 1978; 240: 1607\u20131610.","journal-title":"JAMA"},{"key":"BFhr200986_CR28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0091-7435(87)90087-9","volume":"16","author":"RJ Garrison","year":"1987","unstructured":"Garrison RJ, Kannel WB, Stokes III J, Castelli WP . Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987; 16: 235\u2013251.","journal-title":"Prev Med"},{"key":"BFhr200986_CR29","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(01)06710-1","volume":"358","author":"RS Vasan","year":"2001","unstructured":"Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D . Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358: 1682\u20131686.","journal-title":"Lancet"},{"key":"BFhr200986_CR30","doi-asserted-by":"crossref","first-page":"992","DOI":"10.7326\/0003-4819-140-12-200406150-00008","volume":"140","author":"T Hayashi","year":"2004","unstructured":"Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY . Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med 2004; 140: 992\u20131000.","journal-title":"Ann Intern Med"},{"key":"BFhr200986_CR31","first-page":"23","volume":"723","author":"M Higgins","year":"1988","unstructured":"Higgins M, Kannel W, Garrison R, Pinsky J, Stokes III J . Hazards of obesity\u2013the Framingham experience. Acta Med Scand Suppl 1988; 723: 23\u201336.","journal-title":"Acta Med Scand Suppl"},{"key":"BFhr200986_CR32","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM199602083340607","volume":"334","author":"GM Reaven","year":"1996","unstructured":"Reaven GM, Lithell H, Landsberg L . Hypertension and associated metabolic abnormalities\u2013the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374\u2013381.","journal-title":"N Engl J Med"},{"key":"BFhr200986_CR33","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","volume":"288","author":"HM Lakka","year":"2002","unstructured":"Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT . The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709\u20132716.","journal-title":"JAMA"},{"key":"BFhr200986_CR34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","volume":"140","author":"J Chen","year":"2004","unstructured":"Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J . The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004; 140: 167\u2013174.","journal-title":"Ann Intern Med"},{"key":"BFhr200986_CR35","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/jama.282.21.2027","volume":"282","author":"J He","year":"1999","unstructured":"He J, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK . Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA 1999; 282: 2027\u20132034.","journal-title":"JAMA"},{"key":"BFhr200986_CR36","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2796.2004.01390.x","volume":"256","author":"JC Verhave","year":"2004","unstructured":"Verhave JC, Hillege HL, Burgerhof JG, Janssen WM, Gansevoort RT, Navis GJ, de Zeeuw D, de Jong PE . Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med 2004; 256: 324\u2013330.","journal-title":"J Intern Med"},{"key":"BFhr200986_CR37","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(09)60144-6","volume":"373","author":"J Chen","year":"2009","unstructured":"Chen J, Gu D, Huang J, Rao DC, Jaquish CE, Hixson JE, Chen CS, Chen J, Lu F, Hu D, Rice T, Kelly TN, Hamm LL, Whelton PK, He J . Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Lancet 2009; 373: 829\u2013835.","journal-title":"Lancet"},{"key":"BFhr200986_CR38","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/01.hjh.0000239299.71001.77","volume":"24","author":"T Uzu","year":"2006","unstructured":"Uzu T, Kimura G, Yamauchi A, Kanasaki M, Isshiki K, Araki S, Sugiomoto T, Nishio Y, Maegawa H, Koya D, Haneda M, Kashiwagi A . Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. J Hypertens 2006; 24: 1627\u20131632.","journal-title":"J Hypertens"},{"key":"BFhr200986_CR39","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1161\/01.HYP.0000188049.23233.fb","volume":"46","author":"Z Pausova","year":"2005","unstructured":"Pausova Z, Gaudet D, Gossard F, Bernard M, Kaldunski ML, Jomphe M, Tremblay J, Hudson TJ, Bouchard G, Kotchen TA, Cowley AW, Hamet P . Genome-wide scan for linkage to obesity-associated hypertension in French Canadians. Hypertension 2005; 46: 1280\u20131285.","journal-title":"Hypertension"},{"key":"BFhr200986_CR40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/01.HYP.36.1.14","volume":"36","author":"Z Pausova","year":"2000","unstructured":"Pausova Z, Deslauriers B, Gaudet D, Tremblay J, Kotchen TA, Larochelle P, Cowley AW, Hamet P . Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians. Hypertension 2000; 36: 14\u201319.","journal-title":"Hypertension"},{"key":"BFhr200986_CR41","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/oby.2002.146","volume":"10","author":"R Rosmond","year":"2002","unstructured":"Rosmond R . The glucocorticoid receptor gene and its association to metabolic syndrome. Obes Res 2002; 10: 1078\u20131086.","journal-title":"Obes Res"},{"key":"BFhr200986_CR42","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.amjhyper.2006.07.012","volume":"20","author":"P Russo","year":"2007","unstructured":"Russo P, Lauria F, Loguercio M, Barba G, Arnout J, Cappuccio FP, de Lorgeril M, Donati MB, Iacoviello L, Krogh V, van Dongen M, Siani A . 344C\/T Variant in the promoter of the aldosterone synthase gene (CYP11B2) is associated with metabolic syndrome in men. Am J Hypertens 2007; 20: 218\u2013222.","journal-title":"Am J Hypertens"},{"key":"BFhr200986_CR43","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1152\/physrev.00050.2005","volume":"86","author":"F Lang","year":"2006","unstructured":"Lang F, Bohmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V . Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev 2006; 86: 1151\u20131178.","journal-title":"Physiol Rev"},{"key":"BFhr200986_CR44","first-page":"353","volume":"14","author":"JV Neel","year":"1962","unstructured":"Neel JV . Diabetes mellitus: a \u2018thrifty\u2019 genotype rendered detrimental by \u2018progress\u2019? Am J Hum Genet 1962; 14: 353\u2013362.","journal-title":"Am J Hum Genet"},{"key":"BFhr200986_CR45","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s001090050251","volume":"76","author":"AM Sharma","year":"1998","unstructured":"Sharma AM . The thrifty-genotype hypothesis and its implications for the study of complex genetic disorders in man. J Mol Med 1998; 76: 568\u2013571.","journal-title":"J Mol Med"},{"key":"BFhr200986_CR46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF00399095","volume":"36","author":"DJ Barker","year":"1993","unstructured":"Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM . Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62\u201367.","journal-title":"Diabetologia"},{"key":"BFhr200986_CR47","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1126\/science.2063193","volume":"252","author":"AC Guyton","year":"1991","unstructured":"Guyton AC . Blood pressure control--special role of the kidneys and body fluids. Science 1991; 252: 1813\u20131816.","journal-title":"Science"},{"key":"BFhr200986_CR48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00041552-200303000-00011","volume":"12","author":"JE Hall","year":"2003","unstructured":"Hall JE, Kuo JJ, da Silva AA, de Paula RB, Liu J, Tallam L . Obesity-associated hypertension and kidney disease. Curr Opin Nephrol Hypertens 2003; 12: 195\u2013200.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"BFhr200986_CR49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00041552-200305000-00013","volume":"12","author":"G Coatmellec-Taglioni","year":"2003","unstructured":"Coatmellec-Taglioni G, Ribiere C . Factors that influence the risk of hypertension in obese individuals. Curr Opin Nephrol Hypertens 2003; 12: 305\u2013308.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"BFhr200986_CR50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/01.HYP.0000151325.83008.b4","volume":"45","author":"K Rahmouni","year":"2005","unstructured":"Rahmouni K, Correia ML, Haynes WG, Mark AL . Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005; 45: 9\u201314.","journal-title":"Hypertension"},{"key":"BFhr200986_CR51","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/00004872-200207000-00001","volume":"20","author":"AL Mark","year":"2002","unstructured":"Mark AL, Correia ML, Rahmouni K, Haynes WG . Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens 2002; 20: 1245\u20131250.","journal-title":"J Hypertens"},{"key":"BFhr200986_CR52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1172\/JCI17845","volume":"112","author":"H Masuzaki","year":"2003","unstructured":"Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, Flier JS . Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 2003; 112: 83\u201390.","journal-title":"J Clin Invest"},{"key":"BFhr200986_CR53","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1681\/ASN.2005020193","volume":"16","author":"Y Zheng","year":"2005","unstructured":"Zheng Y, Yamada H, Sakamoto K, Horita S, Kunimi M, Endo Y, Li Y, Tobe K, Terauchi Y, Kadowaki T, Seki G, Fujita T . Roles of insulin receptor substrates in insulin-induced stimulation of renal proximal bicarbonate absorption. J Am Soc Nephrol 2005; 16: 2288\u20132295.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr200986_CR54","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJM198104163041602","volume":"304","author":"ML Tuck","year":"1981","unstructured":"Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M . The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981; 304: 930\u2013933.","journal-title":"N Engl J Med"},{"key":"BFhr200986_CR55","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.HYP.0000154361.47683.d3","volume":"45","author":"S Engeli","year":"2005","unstructured":"Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC, Sharma AM . Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005; 45: 356\u2013362.","journal-title":"Hypertension"},{"key":"BFhr200986_CR56","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1381\/0960892053923734","volume":"15","author":"M Ruano","year":"2005","unstructured":"Ruano M, Silvestre V, Castro R, Garcia-Lescun MC, Rodriguez A, Marco A, Garcia-Blanch G . Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis. Obes Surg 2005; 15: 670\u2013676.","journal-title":"Obes Surg"},{"key":"BFhr200986_CR57","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3109\/07435809809032689","volume":"24","author":"TL Goodfriend","year":"1998","unstructured":"Goodfriend TL, Egan BM, Kelley DE . Aldosterone in obesity. Endocr Res 1998; 24: 789\u2013796.","journal-title":"Endocr Res"},{"key":"BFhr200986_CR58","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/j.1550-8528.1999.tb00418.x","volume":"7","author":"TL Goodfriend","year":"1999","unstructured":"Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ . Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res 1999; 7: 355\u2013362.","journal-title":"Obes Res"},{"key":"BFhr200986_CR59","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/01.HYP.0000113294.06704.64","volume":"43","author":"TL Goodfriend","year":"2004","unstructured":"Goodfriend TL, Ball DL, Egan BM, Campbell WB, Nithipatikom K . Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion. Hypertension 2004; 43: 358\u2013363.","journal-title":"Hypertension"},{"key":"BFhr200986_CR60","doi-asserted-by":"crossref","first-page":"14211","DOI":"10.1073\/pnas.2336140100","volume":"100","author":"M Ehrhart-Bornstein","year":"2003","unstructured":"Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A, Hauner H, McCann SM, Scherbaum WA, Bornstein SR . Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci USA 2003; 100: 14211\u201314216.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFhr200986_CR61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/01.HYP.0000231338.41548.fc","volume":"48","author":"M Bochud","year":"2006","unstructured":"Bochud M, Nussberger J, Bovet P, Maillard MR, Elston RC, Paccaud F, Shamlaye C, Burnier M . Plasma aldosterone is independently associated with the metabolic syndrome. Hypertension 2006; 48: 239\u2013245.","journal-title":"Hypertension"},{"key":"BFhr200986_CR62","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.HYP.0000253258.36141.c7","volume":"49","author":"S Kidambi","year":"2007","unstructured":"Kidambi S, Kotchen JM, Grim CE, Raff H, Mao J, Singh RJ, Kotchen TA . Association of adrenal steroids with hypertension and the metabolic syndrome in blacks. Hypertension 2007; 49: 704\u2013711.","journal-title":"Hypertension"},{"key":"BFhr200986_CR63","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","volume":"91","author":"F Fallo","year":"2006","unstructured":"Fallo F, Veglio F, Bertello C, Sonino N, Della Mea P, Ermani M, Rabbia F, Federspil G, Mulatero P . Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 2006; 91: 454\u2013459.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFhr200986_CR64","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","volume":"351","author":"RS Vasan","year":"2004","unstructured":"Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, Benjamin EJ, Levy D . Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 2004; 351: 33\u201341.","journal-title":"N Engl J Med"},{"key":"BFhr200986_CR65","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCULATIONAHA.107.708537","volume":"116","author":"E Ingelsson","year":"2007","unstructured":"Ingelsson E, Pencina MJ, Tofler GH, Benjamin EJ, Lanier KJ, Jacques PF, Fox CS, Meigs JB, Levy D, Larson MG, Selhub J, D\u2019Agostino Sr RB, Wang TJ, Vasan RS . Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. Circulation 2007; 116: 984\u2013992.","journal-title":"Circulation"},{"key":"BFhr200986_CR66","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/HYPERTENSIONAHA.109.129320","volume":"53","author":"RM Reynolds","year":"2009","unstructured":"Reynolds RM, Walker BR, Phillips DI, Dennison EM, Fraser R, Mackenzie SM, Davies E, Connell JM . Programming of Hypertension. Associations of Plasma Aldosterone in Adult Men and Women With Birthweight, Cortisol, and Blood Pressure. Hypertension 2009; 53: 932\u2013936.","journal-title":"Hypertension"},{"key":"BFhr200986_CR67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1021181527060","volume":"242","author":"MJ Radin","year":"2003","unstructured":"Radin MJ, Holycross BJ, Hoepf TM, McCune SA . Increased salt sensitivity secondary to leptin resistance in SHHF rats is mediated by endothelin. Mol Cell Biochem 2003; 242: 57\u201363.","journal-title":"Mol Cell Biochem"},{"key":"BFhr200986_CR68","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.HYP.0000105624.68174.00","volume":"43","author":"RB de Paula","year":"2004","unstructured":"de Paula RB, da Silva AA, Hall JE . Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension 2004; 43: 41\u201347.","journal-title":"Hypertension"},{"key":"BFhr200986_CR69","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","volume":"117","author":"C Guo","year":"2008","unstructured":"Guo C, Ricchiuti V, Lian BQ, Yao TM, Coutinho P, Romero JR, Li J, Williams GH, Adler GK . Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation 2008; 117: 2253\u20132261.","journal-title":"Circulation"},{"key":"BFhr200986_CR70","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1681\/ASN.V10122488","volume":"10","author":"JM Kumar","year":"1999","unstructured":"Kumar JM, Brooks DP, Olson BA, Laping NJ . Sgk, a putative serine\/threonine kinase, is differentially expressed in the kidney of diabetic mice and humans. J Am Soc Nephrol 1999; 10: 2488\u20132494.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr200986_CR71","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1016\/j.febslet.2006.06.034","volume":"580","author":"KY Kim","year":"2006","unstructured":"Kim KY, Kim HY, Kim JH, Lee CH, Kim DH, Lee YH, Han SH, Lim JS, Cho DH, Lee MS, Yoon S, Kim KI, Yoon DY, Yang Y . Tumor necrosis factor-alpha and interleukin-1beta increases CTRP1 expression in adipose tissue. FEBS Lett 2006; 580: 3953\u20133960.","journal-title":"FEBS Lett"},{"key":"BFhr200986_CR72","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1096\/fj.07-9412com","volume":"22","author":"JH Jeon","year":"2008","unstructured":"Jeon JH, Kim KY, Kim JH, Baek A, Cho H, Lee YH, Kim JW, Kim D, Han SH, Lim JS, Kim KI, Yoon do Y, Kim SH, Oh GT, Kim E, Yang Y . A novel adipokine CTRP1 stimulates aldosterone production. FASEB J 2008; 22: 1502\u20131511.","journal-title":"FASEB J"},{"key":"BFhr200986_CR73","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.06-7970com","volume":"21","author":"M Caprio","year":"2007","unstructured":"Caprio M, Feve B, Claes A, Viengchareun S, Lombes M, Zennaro MC . Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J 2007; 21: 2185\u20132194.","journal-title":"FASEB J"},{"key":"BFhr200986_CR74","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/s-2005-870240","volume":"37","author":"D Kraus","year":"2005","unstructured":"Kraus D, Jager J, Meier B, Fasshauer M, Klein J . Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes. Horm Metab Res 2005; 37: 455\u2013459.","journal-title":"Horm Metab Res"},{"key":"BFhr200986_CR75","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1210\/endo.132.6.8504747","volume":"132","author":"CM Rondinone","year":"1993","unstructured":"Rondinone CM, Rodbard D, Baker ME . Aldosterone stimulated differentiation of mouse 3T3-L1 cells into adipocytes. Endocrinology 1993; 132: 2421\u20132426.","journal-title":"Endocrinology"},{"key":"BFhr200986_CR76","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1210\/jc.2003-030490","volume":"88","author":"JS Williams","year":"2003","unstructured":"Williams JS, Williams GH . 50th anniversary of aldosterone. J Clin Endocrinol Metab 2003; 88: 2364\u20132372.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFhr200986_CR77","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1097\/01.ASN.0000086472.65806.73","volume":"14","author":"TH Hostetter","year":"2003","unstructured":"Hostetter TH, Ibrahim HN . Aldosterone in chronic kidney and cardiac disease. J Am Soc Nephrol 2003; 14: 2395\u20132401.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr200986_CR78","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.amjmed.2006.03.038","volume":"119","author":"M Epstein","year":"2006","unstructured":"Epstein M . Aldosterone blockade: an emerging strategy for abrogating progressive renal disease. Am J Med 2006; 119: 912\u2013919.","journal-title":"Am J Med"},{"key":"BFhr200986_CR79","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm1545","volume":"13","author":"JA Leopold","year":"2007","unstructured":"Leopold JA, Dam A, Maron BA, Scribner AW, Liao R, Handy DE, Stanton RC, Pitt B, Loscalzo J . Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med 2007; 13: 189\u2013197.","journal-title":"Nat Med"},{"key":"BFhr200986_CR80","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J . The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709\u2013717.","journal-title":"N Engl J Med"},{"key":"BFhr200986_CR81","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M . Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309\u20131321.","journal-title":"N Engl J Med"},{"key":"BFhr200986_CR82","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/01.HYP.0000255636.11931.a2","volume":"49","author":"S Shibata","year":"2007","unstructured":"Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T . Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension 2007; 49: 355\u2013364.","journal-title":"Hypertension"},{"key":"BFhr200986_CR83","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","volume":"63","author":"ER Blasi","year":"2003","unstructured":"Blasi ER, Rocha R, Rudolph AE, Blomme EA, Polly ML, McMahon EG . Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int 2003; 63: 1791\u20131800.","journal-title":"Kidney Int"},{"key":"BFhr200986_CR84","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.HYP.0000118519.66430.22","volume":"43","author":"A Nishiyama","year":"2004","unstructured":"Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, Kondo S, Kiyomoto H, Shokoji T, Kimura S, Kohno M, Abe Y . Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone\/salt-induced hypertensive rats. Hypertension 2004; 43: 841\u2013848.","journal-title":"Hypertension"},{"key":"BFhr200986_CR85","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1126\/science.121.3141.368","volume":"121","author":"H Selye","year":"1955","unstructured":"Selye H . Anticortisol action of aldosterone. Science 1955; 121: 368\u2013369.","journal-title":"Science"},{"key":"BFhr200986_CR86","first-page":"893","volume":"120","author":"CG Brilla","year":"1992","unstructured":"Brilla CG, Weber KT . Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med 1992; 120: 893\u2013901.","journal-title":"J Lab Clin Med"},{"key":"BFhr200986_CR87","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/01.HYP.0000067463.13172.EA","volume":"41","author":"WB White","year":"2003","unstructured":"White WB, Duprez D, St Hillaire R, Krause S, Roniker B, Kuse-Hamilton J, Weber MA . Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension. Hypertension 2003; 41: 1021\u20131026.","journal-title":"Hypertension"},{"key":"BFhr200986_CR88","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.amjcard.2004.01.007","volume":"93","author":"GH Williams","year":"2004","unstructured":"Williams GH, Burgess E, Kolloch RE, Ruilope LM, Niegowska J, Kipnes MS, Roniker B, Patrick JL, Krause SL . Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension. Am J Cardiol 2004; 93: 990\u2013996.","journal-title":"Am J Cardiol"},{"key":"BFhr200986_CR89","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2215\/CJN.00240106","volume":"1","author":"M Epstein","year":"2006","unstructured":"Epstein M, Williams GH, Weinberger M, Lewin A, Krause S, Mukherjee R, Patni R, Beckerman B . Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes. Clin J Am Soc Nephrol 2006; 1: 940\u2013951.","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFhr200986_CR90","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/01.HYP.0000044937.95080.E9","volume":"41","author":"A Sato","year":"2003","unstructured":"Sato A, Hayashi K, Naruse M, Saruta T . Effectiveness of aldosterone blockade in patients with diabetic nephropathy. Hypertension 2003; 41: 64\u201368.","journal-title":"Hypertension"},{"key":"BFhr200986_CR91","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2215\/CJN.01040905","volume":"1","author":"A Chrysostomou","year":"2006","unstructured":"Chrysostomou A, Pedagogos E, MacGregor L, Becker GJ . Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker. Clin J Am Soc Nephrol 2006; 1: 256\u2013262.","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFhr200986_CR92","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1038\/sj.ki.5001854","volume":"70","author":"S Bianchi","year":"2006","unstructured":"Bianchi S, Bigazzi R, Campese VM . Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. Kidney Int 2006; 70: 2116\u20132123.","journal-title":"Kidney Int"},{"key":"BFhr200986_CR93","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1681\/ASN.2005111196","volume":"17","author":"SY Han","year":"2006","unstructured":"Han SY, Kim CH, Kim HS, Jee YH, Song HK, Lee MH, Han KH, Kim HK, Kang YS, Han JY, Kim YS, Cha DR . Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats. J Am Soc Nephrol 2006; 17: 1362\u20131372.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr200986_CR94","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1681\/ASN.2004090804","volume":"16","author":"JC Aldigier","year":"2005","unstructured":"Aldigier JC, Kanjanbuch T, Ma LJ, Brown NJ, Fogo AB . Regression of existing glomerulosclerosis by inhibition of aldosterone. J Am Soc Nephrol 2005; 16: 3306\u20133314.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr200986_CR95","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncpneph0575","volume":"3","author":"AS Bomback","year":"2007","unstructured":"Bomback AS, Klemmer PJ . The incidence and implications of aldosterone breakthrough. Nat Clin Pract Nephrol 2007; 3: 486\u2013492.","journal-title":"Nat Clin Pract Nephrol"},{"key":"BFhr200986_CR96","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1440-1797.2006.00665.x","volume":"11","author":"Y Horita","year":"2006","unstructured":"Horita Y, Taura K, Taguchi T, Furusu A, Kohno S . Aldosterone breakthrough during therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathy. Nephrology (Carlton) 2006; 11: 462\u2013466.","journal-title":"Nephrology (Carlton)"},{"key":"BFhr200986_CR97","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1681\/ASN.2005010106","volume":"16","author":"M Kurella","year":"2005","unstructured":"Kurella M, Lo JC, Chertow GM . Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16: 2134\u20132140.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr200986_CR98","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/j.ajkd.2006.06.003","volume":"48","author":"T Ninomiya","year":"2006","unstructured":"Ninomiya T, Kiyohara Y, Kubo M, Yonemoto K, Tanizaki Y, Doi Y, Hirakata H, Iida M . Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Am J Kidney Dis 2006; 48: 383\u2013391.","journal-title":"Am J Kidney Dis"},{"key":"BFhr200986_CR99","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.ki.5000050","volume":"69","author":"H Tanaka","year":"2006","unstructured":"Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K . Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 2006; 69: 369\u2013374.","journal-title":"Kidney Int"},{"key":"BFhr200986_CR100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1096-130","volume":"14","author":"K Takaya","year":"1996","unstructured":"Takaya K, Ogawa Y, Hiraoka J, Hosoda K, Yamori Y, Nakao K, Koletsky RJ . Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat Genet 1996; 14: 130\u2013131.","journal-title":"Nat Genet"},{"key":"BFhr200986_CR101","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10157-008-0034-9","volume":"12","author":"M Nagase","year":"2008","unstructured":"Nagase M, Fujita T . Aldosterone and glomerular podocyte injury. Clin Exp Nephrol 2008; 12: 233\u2013242.","journal-title":"Clin Exp Nephrol"},{"key":"BFhr200986_CR102","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/01.ASN.0000115398.92270.30","volume":"15","author":"E Ritz","year":"2004","unstructured":"Ritz E, McClellan WM . Overview: increased cardiovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences. J Am Soc Nephrol 2004; 15: 513\u2013516.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr200986_CR103","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1291\/hypres.27.303","volume":"27","author":"A Sato","year":"2004","unstructured":"Sato A, Saruta T . Aldosterone-induced organ damage: plasma aldosterone level and inappropriate salt status. Hypertens Res 2004; 27: 303\u2013310.","journal-title":"Hypertens Res"},{"key":"BFhr200986_CR104","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1210\/mend.13.1.0226","volume":"13","author":"C Massaad","year":"1999","unstructured":"Massaad C, Houard N, Lombes M, Barouki R . Modulation of human mineralocorticoid receptor function by protein kinase A. Mol Endocrinol 1999; 13: 57\u201365.","journal-title":"Mol Endocrinol"},{"key":"BFhr200986_CR105","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1074\/jbc.M607741200","volume":"282","author":"K Yokota","year":"2007","unstructured":"Yokota K, Shibata H, Kurihara I, Kobayashi S, Suda N, Murai-Takeda A, Saito I, Kitagawa H, Kato S, Saruta T, Itoh H . Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9. J Biol Chem 2007; 282: 1998\u20132010.","journal-title":"J Biol Chem"},{"key":"BFhr200986_CR106","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.270.5241.1491","volume":"270","author":"S Kato","year":"1995","unstructured":"Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P . Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995; 270: 1491\u20131494.","journal-title":"Science"},{"key":"BFhr200986_CR107","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.283.5406.1317","volume":"283","author":"J Yanagisawa","year":"1999","unstructured":"Yanagisawa J, Yanagi Y, Masuhiro Y, Suzawa M, Watanabe M, Kashiwagi K, Toriyabe T, Kawabata M, Miyazono K, Kato S . Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 1999; 283: 1317\u20131321.","journal-title":"Science"},{"key":"BFhr200986_CR108","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1074\/jbc.M005547200","volume":"276","author":"LF Su","year":"2001","unstructured":"Su LF, Knoblauch R, Garabedian MJ . Rho GTPases as modulators of the estrogen receptor transcriptional response. J Biol Chem 2001; 276: 3231\u20133237.","journal-title":"J Biol Chem"},{"key":"BFhr200986_CR109","doi-asserted-by":"crossref","first-page":"9118","DOI":"10.1074\/jbc.M509339200","volume":"281","author":"T Kino","year":"2006","unstructured":"Kino T, Souvatzoglou E, Charmandari E, Ichijo T, Driggers P, Mayers C, Alatsatianos A, Manoli I, Westphal H, Chrousos GP, Segars JH . Rho family Guanine nucleotide exchange factor Brx couples extracellular signals to the glucocorticoid signaling system. J Biol Chem 2006; 281: 9118\u20139126.","journal-title":"J Biol Chem"},{"key":"BFhr200986_CR110","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1038\/sj.onc.1202921","volume":"18","author":"A Togawa","year":"1999","unstructured":"Togawa A, Miyoshi J, Ishizaki H, Tanaka M, Takakura A, Nishioka H, Yoshida H, Doi T, Mizoguchi A, Matsuura N, Niho Y, Nishimune Y, Nishikawa S, Takai Y . Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIalpha. Oncogene 1999; 18: 5373\u20135380.","journal-title":"Oncogene"},{"key":"BFhr200986_CR111","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.1073\/pnas.0307512101","volume":"101","author":"Y Gao","year":"2004","unstructured":"Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y . Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci USA 2004; 101: 7618\u20137623.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFhr200986_CR112","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nm1274","volume":"11","author":"JA Cancelas","year":"2005","unstructured":"Cancelas JA, Lee AW, Prabhakar R, Stringer KF, Zheng Y, Williams DA . Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization. Nat Med 2005; 11: 886\u2013891.","journal-title":"Nat Med"},{"key":"BFhr200986_CR113","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1152\/physrev.2001.81.1.153","volume":"81","author":"Y Takai","year":"2001","unstructured":"Takai Y, Sasaki T, Matozaki T . Small GTP-binding proteins. Physiol Rev 2001; 81: 153\u2013208.","journal-title":"Physiol Rev"},{"key":"BFhr200986_CR114","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cell.2008.01.052","volume":"133","author":"X Wu","year":"2008","unstructured":"Wu X, Tu X, Joeng KS, Hilton MJ, Williams DA, Long F . Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. Cell 2008; 133: 340\u2013353.","journal-title":"Cell"},{"key":"BFhr200986_CR115","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1083\/jcb.200604073","volume":"175","author":"T Kawashima","year":"2006","unstructured":"Kawashima T, Bao YC, Nomura Y, Moon Y, Tonozuka Y, Minoshima Y, Hatori T, Tsuchiya A, Kiyono M, Nosaka T, Nakajima H, Williams DA, Kitamura T . Rac1 and a GTPase-activating protein, MgcRacGAP, are required for nuclear translocation of STAT transcription factors. J Cell Biol 2006; 175: 937\u2013946.","journal-title":"J Cell Biol"},{"key":"BFhr200986_CR116","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.1123348","volume":"312","author":"JT Bridgham","year":"2006","unstructured":"Bridgham JT, Carroll SM, Thornton JW . Evolution of hormone-receptor complexity by molecular exploitation. Science 2006; 312: 97\u2013101.","journal-title":"Science"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr200986.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr200986","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr200986.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:05:11Z","timestamp":1684415111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr200986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,12]]},"references-count":116,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["BFhr200986"],"URL":"https:\/\/doi.org\/10.1038\/hr.2009.86","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,12]]}}}